Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
654K
-
Shares change
-
+85.1K
-
Total reported value, excl. options
-
$1.5M
-
Value change
-
+$194K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$2.29
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q3 2022
12 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q3 2022.
HCW Biologics Inc. - COM (HCWB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 654K shares
.
Largest 10 shareholders include HighTower Advisors, LLC (226K shares), GEODE CAPITAL MANAGEMENT, LLC (131K shares), VANGUARD GROUP INC (95.4K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (72.6K shares), BlackRock Inc. (41.7K shares), TWO SIGMA INVESTMENTS, LP (38K shares), STATE STREET CORP (21.4K shares), Cresset Asset Management, LLC (17.6K shares), Tower Research Capital LLC (TRC) (6.42K shares), and MORGAN STANLEY (3.4K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.